TREM2 and myocardial infarction: During the late stage of MI (days 5–7), there was an up-regulation of Trem2 expression in macrophages, and the administration of soluble Trem2 in the animal model substantially enhanced the structure and function of the infarcted heart, indicating the therapeutic promise of this signaling pathway for the future.